EFFECT OF LIRAGLUTIDE ON BODY WEIGHT IN OVERWEIGHT OR OBESE SUBJECTS WITH TYPE 2 DIABETES; A 56 WEEK RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED, THREE ARMED PARALLEL GROUP, MULTI-CENTRE, MULTINATIONAL TRIAL WITH A 12 WEEK OBSERVATIONAL FOLLOW-UP PERIOD
Principal Investigator(s)
DeFronzo,Ralph A
Funded by
NOVO NORDISK PHARMACEUTICAL
Research Start Date
Status
Inactive